Chemical Compound

Stanozolol; 2'H-Androst-2-eno[3,2-c]pyrazol-17-ol, 17-methyl-, (5alpha,17beta)-; 2'H-5alpha-Androst-2-eno[3,2-c]pyrazol-17beta-ol, 17-methyl- (8CI); Cyclopenta[7,8]phenanthro[2,3-c]pyrazol-1-ol, 1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-hexadecahydro-1,10a,12a-trimethyl- (6CI,7CI); (5alpha,17beta)-17-Methyl-2'H-androst-2-eno[3,2-c]pyrazol-17-ol; 17-Methyl-5alpha-androstano[3,2-c]pyrazol-17beta-ol; 17-Methyl-pyrazolo[4',3':2,3]-5alpha-androstan-17beta-ol; 17alpha-Methyl-17beta-hydroxy-5alpha-androstano(3,2-c)pyrazole; 17beta-Hydroxy-17-methyl-5alpha-androstano[3,2-c]pyrazole; Anabol; Androstanazol; Androstanazole; Androstanazolestanazol; Estazol; NSC 233046; NSC 43193; Stanabolic; Stanazolol; Stromba; Strombaject; Tevabolin; Win 14833; Winstroid; Winstrol; Winstrol Depot; Winstrol V

CAS Registry Number 10418-03-8
Stanozolol; 2'H-Androst-2-eno[3,2-c]pyrazol-17-ol, 17-methyl-, (5alpha,17beta)-; 2'H-5alpha-Androst-2-eno[3,2-c]pyrazol-17beta-ol, 17-methyl- (8CI); Cyclopenta[7,8]phenanthro[2,3-c]pyrazol-1-ol, 1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-hexadecahydro-1,10a,12a-trimethyl- (6CI,7CI); (5alpha,17beta)-17-Methyl-2'H-androst-2-eno[3,2-c]pyrazol-17-ol; 17-Methyl-5alpha-androstano[3,2-c]pyrazol-17beta-ol; 17-Methyl-pyrazolo[4',3':2,3]-5alpha-androstan-17beta-ol; 17alpha-Methyl-17beta-hydroxy-5alpha-androstano(3,2-c)pyrazole; 17beta-Hydroxy-17-methyl-5alpha-androstano[3,2-c]pyrazole; Anabol; Androstanazol; Androstanazole; Androstanazolestanazol; Estazol; NSC 233046; NSC 43193; Stanabolic; Stanazolol; Stromba; Strombaject; Tevabolin; Win 14833; Winstroid; Winstrol; Winstrol Depot; Winstrol V 结构式
Primary record

Stanozolol; 2'H-Androst-2-eno[3,2-c]pyrazol-17-ol, 17-methyl-, (5alpha,17beta)-; 2'H-5alpha-Androst-2-eno[3,2-c]pyrazol-17beta-ol, 17-methyl- (8CI); Cyclopenta[7,8]phenanthro[2,3-c]pyrazol-1-ol, 1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-hexadecahydro-1,10a,12a-trimethyl- (6CI,7CI); (5alpha,17beta)-17-Methyl-2'H-androst-2-eno[3,2-c]pyrazol-17-ol; 17-Methyl-5alpha-androstano[3,2-c]pyrazol-17beta-ol; 17-Methyl-pyrazolo[4',3':2,3]-5alpha-androstan-17beta-ol; 17alpha-Methyl-17beta-hydroxy-5alpha-androstano(3,2-c)pyrazole; 17beta-Hydroxy-17-methyl-5alpha-androstano[3,2-c]pyrazole; Anabol; Androstanazol; Androstanazole; Androstanazolestanazol; Estazol; NSC 233046; NSC 43193; Stanabolic; Stanazolol; Stromba; Strombaject; Tevabolin; Win 14833; Winstroid; Winstrol; Winstrol Depot; Winstrol V

库存
9,639 克
纯度
99.8 %
CAS
10418-03-8

化合物标识与属性

CAS
10418-03-8
PubChem CID
25249
SMILES
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CC[C@@H]4[C@@]3(CC5=C(C4)NN=C5)C
Canonical SMILES
C[C@]12Cc3cn[nH]c3C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O

名称与同义词

  • stanozolol
  • Winstrol
  • Androstanazole
  • Androstanazol
  • Stromba
  • Stanazolol
  • Tevabolin
  • Strombaject
  • Winstrol Depot
  • Estazol
  • Estanozolol
  • Winstroid
  • Winstrol V
  • Stanozololum
  • Anabol
  • Methylstanazol
  • Stanozolol ciii
  • Stanozolo
  • stanozol
  • stanozololo
  • Winstrol-V
  • Stanozolo [DCIT]
  • Stanozolol CRS
  • Stanozolol powder
  • Androstanazole (VAN)
  • 10418-03-8
  • Androstanazolestanazol
  • Winstrol (TN)
  • Winstrol-V Tablets
  • Stanozolol degrees
  • Stanozolol (1'H form)
  • Winstrol|||Stanabol
  • Stanozololum [INN-Latin]
  • WIN 14833
  • Estanozolol [INN-Spanish]
  • Stanozolol (2'H form)
  • RefChem:6260
  • A1IOS
  • STANOZOLOL [MI]
  • DTXSID3044128
  • STANOZOLOL [INN]
  • STANOZOLOL [JAN]
  • 4R1VB9P8V3
  • STANOZOLOL [HSDB]
  • STANOZOLOL [USAN]
  • UNII-4R1VB9P8V3
  • NSC-43193
  • STANOZOLOL [VANDF]
  • WIN-14833
  • D08QKJ
  • HSDB 3185
  • AC1L18QU
  • STANOZOLOL [MART.]
  • CHEBI:9249
  • Winstrol-V Chewable Tablets
  • STANOZOLOL [WHO-DD]
  • stanozolol--dea schedule iii
  • DEA No. 4000
  • SCHEMBL44099
  • SCHEMBL44101
  • DTXCID1024128
  • Stanozolol (JAN/USP/INN)
  • C21H32N2O
  • MLS001424321
  • Winstrol-V Sterile Suspension
  • EINECS 233-894-8
  • LKAJKIOFIWVMDJ-IYRCEVNGSA-N
  • NSC 43193
  • Stanozolol, analytical standard
  • AC1Q59E2
  • Stanozolol [USAN:BAN:INN:JAN]
  • STANOZOLOL [GREEN BOOK]
  • C21H32N2O.CH4
  • CHEMBL2079587
  • NSC 233046
  • NSC-233046
  • NSC43193
  • STANOZOLOL [ORANGE BOOK]
  • WIN14833
  • GTPL10369
  • A14AA02
  • STANOZOLOL [EP MONOGRAPH]
  • STANOZOLOL CIII [USP-RS]
  • GLXC-10566
  • HMS2052H11
  • HMS2090P03
  • HMS3713K06
  • STANOZOLOL [USP MONOGRAPH]
  • Stanozolol [USAN:INN:BAN:JAN]
  • BCP12548
  • CID25249
  • HY-B0899
  • Stanozolol [USAN:USP:INN:BAN:JAN]
  • Stanozolol, 1mg/ml in Acetonitrile
  • ZINC4097376
  • Tox21_113993
  • C21-H32-N2-O
  • CID:25249
  • MFCD00133084
  • MSK8501-100A
  • NSC233046
  • AKOS005067278
  • MSK8501-1000A
  • Stanozolol 1.0 mg/ml in Acetonitrile
  • ACN-031989
  • AM84316
  • CCG-101186
  • CCG-220452
  • CS-4363
  • CS-O-02374
  • DB06718
  • EBD2201785
  • J3.432K
  • NC00436
  • NCGC00344550-01
  • 17-Methyl-5alpha-androstano(3,2-c)pyrazol-17beta-ol
  • AC-16140
  • AC-33164
  • AS-35198
  • BC210011
  • CPD000058878
  • FS156771
  • LS-19415
  • LS-19530
  • SID:53790969
  • SMR000058878
  • 17-Methyl-2'H-5alpha-androst-2-eno(3,2-c)pyrazol-17beta-ol
  • CAS-10418-03-8
  • J332.003K
  • TL8000176
  • 17beta-Hydroxy-17-methyl-5alpha-androstano(3,2-c)pyrazole
  • FT-0701712
  • NS00008736
  • 17-beta-Hydroxy-17-alpha-methylandrostano(3,2-c)pyrazole
  • 17beta-Hydroxy-17alpha-methyl-androstano(3,2-c)pyrazole
  • 2'H-5alpha-Androst-2-eno(3,2-c)pyrazol-17beta-ol, 17-methyl-
  • 2'H-Androst-2-eno(3,2-c)pyrazol-17-ol, 17-methyl-, (5alpha,17beta)-
  • C07311
  • D00444
  • Stanozolol Solution in Acetonitrile, 100ug/mL
  • 17-Methyl-5a-androstano[3,2-c]pyrazol-17b-ol
  • 17-Methyl-pyrazolo(4',3':2,3)-5alpha-androstan-17beta-ol
  • 17-Methylpyrazolo(4',3':2,3)-5alpha-androstan-17beta-ol
  • AB00443942-03
  • AB00443942-05
  • Stanozolol Solution in Acetonitrile, 1000ug/mL
  • 17alpha-Methyl-17beta-hydroxy-5alpha-androstano(3,2-c)pyrazole
  • 418S038
  • D013197
  • SR-05000001522
  • 2,3-(4',3'-Pyrazolo)-5alpha-androstan-17beta-ol, 17-methyl-
  • I06-2218
  • SR-05000001522-1
  • SR-05000001522-2
  • 17a-Methyl-17b-hydroxy-5a-androstano(3,2-c)pyrazole
  • 17b-Hydroxy-17-methyl-5a-androstano[3,2-c]pyrazole
  • 17b-Hydroxy-17a-methyl-5a-androstano[3,2-c]pyrazole
  • BRD-K46791647-001-01-2
  • Q63409446
  • (1S,2S,10S,13R,14S,17S,18S)-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5-dien-17-ol
  • (1S,3aS,3bR,5aS,10aS,10bS,12aS)-1,10a,12a-trimethyl-1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-hexadecahydrocyclopenta[5,6]naphtho[1,2-f]indazol-1-ol
  • 17-Methyl-pyrazolo[4',3':2,3]-5a-androstan-17b-ol
  • Cyclopenta(7,8)phenanthro(2,3-c)pyrazol-1-ol, 1,2,3,3a,3b,4,5,5a,6,8,10,10a,10b,11,12,12a-hexadecahydro-1,10a,12a-trimethyl-
  • Stanozolol, European Pharmacopoeia (EP) Reference Standard
  • (5a,17b)-17-methyl-2'H-Androst-2-eno[3,2-c]pyrazol-17-ol
  • 1'H-Androstano(3,2-c)pyrazol-17-ol, 17-methyl-, (5-alpha,17-beta)-
  • 1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-Hexadecahydro-1,10a,12a-trimethylcyclopenta(7,8)-phenanthro(2,3-c)pyrazol-1-ol
  • 17-Methyl-1 H-5alpha-androstano[3,2-c]pyrazol-17beta-ol
  • 2,3'-Pyrazolo)-5.alpha.-androstan-17.beta.-ol, 17-methyl-
  • 302-96-5
  • 17-Methyl-2 H-5alpha-androst-2-eno[3,2-c]pyrazol-17beta-ol
  • 17-Methyl-2'H-5.alpha.-androst-2-eno(3,2-c)pyrazol-17.beta.-ol
  • 17-METHYL-5.ALPHA.-ANDROSTANO(3,2-C)PYRAZOL-17.BETA.-OL
  • 2'H-5a-Androst-2-eno[3,2-c]pyrazol-17b-ol, 17-methyl- (8CI)
  • Cyclopenta[7,8]phenanthro-[2,3-c]pyrazol-1-ol, 1,2,3,3a,3b,4
  • (1S,3aS,3bR,5aS,10aS,10bS,12aS)-1,10a,12a-trimethyl-1,2,3,3a,3b,4,5,5a,6,8,10,10a,10b,11,12,12a-hexadecahydrocyclopenta[5,6]naphtho[1,2-f]indazol-1-ol
  • (5-alpha,17-beta)-17-Methyl-2'H-androst-2-eno[3,2-c]pyrazol-17-ol
  • 1'H-ANDROSTANO(3,2-C)PYRAZOL-17-OL, 17-METHYL-, (5alpha,17beta)-
  • 1'H-Androstano[3,2-c]pyrazol-17-ol, 17-methyl-, (5.alpha.,17.beta.)-
  • 17966-55-1
  • 17alpha-Methyl-17beta-hydroxy-5alpha-androst-2-eno(3,2-c)-pyrazole
  • 17alpha-Methyl-2 H-5alpha-androst-2-eno[3,2-c]pyrazol-17beta-ol
  • 2'H-Androst-2-eno[3,2-c]pyrazol-17-ol, 17-methyl-, (5alpha,17beta)-
  • Cyclopenta(7,8)phenanthro(2,3-c)pyrazol-1-ol, 1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-hexadecahydro-1,10a,12a-trimethyl-
  • 1'H-ANDROSTANO(3,2-C)PYRAZOL-17-OL, 17-METHYL-, (5.ALPHA.,17.BETA.)-
  • 17.BETA.-HYDROXY-17.ALPHA.-METHYL-5.ALPHA.-ANDROSTANO(3,2-C)PYRAZOLE
  • 2'H-ANDROST-2-ENO(3,2-C)PYRAZOL-17-OL, 17-METHYL-, (5.ALPHA.,17.BETA.)
  • 2'H-Androst-2-eno[3,2-c]pyrazol-17-ol, 17-methyl-, (5.alpha.,17.beta.)-
  • Cyclopenta[7,8]phenanthro[2,3-c]pyrazole, 2'H-androst-2-eno[3,2-c]pyrazol-17-ol deriv.
  • (1S,2S,10S,13R,14S,17S,18S)-2,17,18-trimethyl-6,7-diazapentacyclo(11.7.0.0^(2,10).0^(4,8).0^(14,18))icosa-4(8),5-dien-17-ol
  • (1S,2S,10S,13R,14S,17S,18S)-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.0^{2,10}.0^{4,8}.0^{14,18}]icosa-4(8),5-dien-17-ol
  • (1S,2S,10S,13R,14S,17S,18S)-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4,7-dien-17-ol
  • 1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-hexadecahydro-1,10a,12a-trimethyl-Cyclopenta[7,8]phenanthro[2,3-c]pyrazol-1-ol
  • 233-894-8
  • Cyclopenta[7,3-c]pyrazol-1-ol, 1,2,3,3a,3b,4,5,5a,6,8,10,10a,10b,11,12,12a-hexadecahydro-1,10a,12a-trimethyl-
  • Stanozolol; 2'H-Androst-2-eno[3,2-c]pyrazol-17-ol, 17-methyl-, (5alpha,17beta)-; 2'H-5alpha-Androst-2-eno[3,2-c]pyrazol-17beta-ol, 17-methyl- (8CI); Cyclopenta[7,8]phenanthro[2,3-c]pyrazol-1-ol, 1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-hexadecahydro-1,10a,12a-trimethyl- (6CI,7CI); (5alpha,17beta)-17-Methyl-2'H-androst-2-eno[3,2-c]pyrazol-17-ol; 17-Methyl-5alpha-androstano[3,2-c]pyrazol-17beta-ol; 17-Methyl-pyrazolo[4',3':2,3]-5alpha-androstan-17beta-ol; 17alpha-Methyl-17beta-hydroxy-5alpha-androstano(3,2-c)pyrazole; 17beta-Hydroxy-17-methyl-5alpha-androstano[3,2-c]pyrazole; Anabol; Androstanazol; Androstanazole; Androstanazolestanazol; Estazol; NSC 233046; NSC 43193; Stanabolic; Stanazolol; Stromba; Strombaject; Tevabolin; Win 14833; Winstroid; Winstrol; Winstrol Depot; Winstrol V